Infectious disease testing encompasses molecular diagnostics, immunoassays, and rapid antigen tests detecting bacterial, viral, fungal, and parasitic pathogens enabling early intervention. The infectious disease testing market size was valued at USD 28 billion in 2025 and is projected to grow from USD 30 billion in 2026 to USD 60 billion by 2034 at a CAGR of 7% during the forecast...